|
1
|
Lwin T, Hazlehurst LA, Li Z, Dessureault
S, Sotomayor E, Moscinski LC, Dalton WS and Tao J: Bone marrow
stromal cells prevent apoptosis of lymphoma cells by upregulation
of anti-apoptotic proteins associated with activation of NF-kappaB
(RelB/p52) in non-Hodgkin's lymphoma cells. Leukemia. 21:1521–1531.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ding BB, Yu JJ, Yu RY, Mendez LM,
Shaknovich R, Zhang Y, Cattoretti G and Ye BH: Constitutively
activated STAT3 promotes cell proliferation and survival in the
activated B-cell subtype of diffuse large B-cell lymphomas. Blood.
111:1515–1523. 2008. View Article : Google Scholar
|
|
3
|
Wang K, Jiang Y, Zheng W, Liu Z, Li H, Lou
J, Gu M and Wang X: Silencing of human
phosphatidylethanolamine-binding protein 4 enhances
rituximab-induced death and chemosensitization in B-cell lymphoma.
PLoS One. 8:e568292013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Y, Fei M, Cheng C, Zhang D, Lu J, He
S, Zhao Y, Wang Y and Shen A: Jun activation domain-binding protein
1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas. Cancer
Biol Ther. 7:460–467. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hang Q, Fei M, Hou S, Ni Q, Lu C, Zhang G,
Gong P, Guan C, Huang X and He S: Expression of Spy1 protein in
human non-Hodgkin's lymphomas is correlated with phosphorylation of
p27 Kip1 on Thr187 and cell proliferation. Med Oncol. 29:3504–3514.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Y, Fei M, Wang Y, Lu M, Cheng C and
Shen A: Expression of Foxo3a in non-Hodgkin's lymphomas is
correlated with cell cycle inhibitor p27. Eur J Haematol. 81:83–93.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lwin T, Lin J, Choi YS, Zhang X, Moscinski
LC, Wright KL, Sotomayor EM, Dalton WS and Tao J: Follicular
dendritic cell-dependent drug resistance of non-Hodgkin lymphoma
involves cell adhesion-mediated Bim down-regulation through
induction of microRNA-181a. Blood. 116:5228–5236. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lwin T, Crespo LA, Wu A, Dessureault S,
Shu HB, Moscinski LC, Sotomayor E, Dalton WS and Tao J: Lymphoma
cell adhesion-induced expression of B cell-activating factor of the
TNF family in bone marrow stromal cells protects non-Hodgkin's B
lymphoma cells from apoptosis. Leukemia. 23:170–177. 2009.
View Article : Google Scholar
|
|
9
|
Mraz M, Zent CS, Church AK, Jelinek DF, Wu
X, Pospisilova S, Ansell SM, Novak AJ, Kay NE, Witzig TE and
Nowakowski GS: Bone marrow stromal cells protect lymphoma B-cells
from rituximab-induced apoptosis and targeting integrin alpha-4-β-1
(VLA-4) with natalizumab can overcome this resistance. Br J
Haematol. 155:53–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hazlehurst LA, Argilagos RF, Emmons M,
Boulware D, Beam CA, Sullivan DM and Dalton WS: Cell adhesion to
fibronectin (CAM-DR) influences acquired mitoxantrone resistance in
U937 cells. Cancer Res. 66:2338–2345. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Westhoff MA, Zhou S, Bachem MG, Debatin KM
and Fulda S: Identification of a novel switch in the dominant forms
of cell adhesion-mediated drug resistance in glioblastoma cells.
Oncogene. 27:5169–5181. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weber A, Kristiansen I, Johannsen M,
Oelrich B, Scholmann K, Gunia S, May M, Meyer HA, Behnke S, Moch H
and Kristiansen G: The FUSE binding proteins FBP1 and FBP3 are
potential c-myc regulators in renal, but not in prostate and
bladder cancer. BMC Cancer. 8:3692008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jang M, Park BC, Kang S, Chi SW, Cho S,
Chung SJ, Lee SC, Bae KH and Park SG: Far upstream element-binding
protein-1, a novel caspase substrate, acts as a cross-talker
between apoptosis and the c-myc oncogene. Oncogene. 28:1529–1536.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thiede B, Dimmler C, Siejak F and Rudel T:
Predominant identification of RNA-binding proteins in Fas-induced
apoptosis by proteome analysis. J Biol Chem. 276:26044–26050. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rabenhorst U, Beinoraviciute-Kellner R,
Brezniceanu ML, Joos S, Devens F, Lichter P, Rieker RJ, Trojan J,
Chung HJ, Levens DL and Zörnig M: Overexpression of the far
upstream element binding protein 1 in hepatocellular carcinoma is
required for tumor growth. Hepatology. 50:1121–1129. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hazlehurst LA, Damiano JS, Buyuksal I,
Pledger WJ and Dalton WS: Adhesion to fibronectin via beta1
integrins regulates p27kip1 levels and contributes to cell adhesion
mediated drug resistance (CAM-DR). Oncogene. 19:4319–4327. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shain KH, Yarde DN, Meads MB, Huang M,
Jove R, Hazlehurst LA and Dalton WS: Beta1 integrin adhesion
enhances IL-6-mediated STAT3 signaling in myeloma cells:
Implications for microenvironment influence on tumor survival and
proliferation. Cancer Res. 69:1009–1015. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Naz E, Mirza T, Aziz S, Danish F, Siddiqui
ST and Ali A: Frequency and clinicopathologic correlation of
different types of non Hodgkin's lymphoma according to WHO
classification. J Pak Med Assoc. 61:260–263. 2011.PubMed/NCBI
|
|
19
|
Filtenborg-Barnkob BE and Bzorek M:
Expression of anaplastic lymphoma kinase in Merkel cell carcinomas.
Hum Pathol. 44:1656–1664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li M, Yang X, Shi H, Ren H, Chen X, Zhang
S, Zhu J and Zhang J: Downregulated expression of the
cyclase-associated protein 1 (CAP1) reduces migration in esophageal
squamous cell carcinoma. Jpn J Clin Oncol. 43:856–864. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Wang Y, Cheng C, Chen Y, Shi S, Qin
J, Xiao F, Zhou D, Lu M, Lu Q and Shen A: A relationship between
p27(kip1) and Skp2 after adult brain injury: Implications for glial
proliferation. J Neurotrauma. 27:361–371. 2010. View Article : Google Scholar
|
|
22
|
Dong C, Yuan T, Wu Y, Wang Y, Fan TW,
Miriyala S, Lin Y, Yao J, Shi J, Kang T, et al: Loss of FBP1 by
Snail-mediated repression provides metabolic advantages in
basal-like breast cancer. Cancer Cell. 23:316–331. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Malz M, Weber A, Singer S, Riehmer V,
Bissinger M, Riener MO, Longerich T, Soll C, Vogel A, Angel P, et
al: Overexpression of far upstream element binding proteins: A
mechanism regulating proliferation and migration in liver cancer
cells. Hepatology. 50:1130–1139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen M, Zhang J, Li N, Qian Z, Zhu M, Li
Q, Zheng J, Wang X and Shi G: Promoter hypermethylation mediated
downregulation of FBP1 in human hepatocellular carcinoma and colon
cancer. PLoS One. 6:e255642011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Singer S, Malz M, Herpel E, Warth A,
Bissinger M, Keith M, Muley T, Meister M, Hoffmann H, Penzel R, et
al: Coordinated expression of stathmin family members by far
upstream sequence element-binding protein-1 increases motility in
non-small cell lung cancer. Cancer Res. 69:2234–2243. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ding Z, Liu X, Liu Y, Zhang J, Huang X,
Yang X, Yao L, Cui G and Wang D: Expression of far upstream element
(FUSE) binding protein 1 in human glioma is correlated with c-Myc
and cell proliferation. Mol Carcinog. 54:405–415. 2015. View Article : Google Scholar
|
|
27
|
Burger JA, Ghia P, Rosenwald A and
Caligaris-Cappio F: The microenvironment in mature B-cell
malignancies: A target for new treatment strategies. Blood.
114:3367–3375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fei M, Hang Q, Hou S, He S and Ruan C:
Adhesion to fibronectin induces p27(kip1) nuclear accumulation
through down-regulation of Jab1 and contributes to cell
adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells. Mol
Cell Biochem. 386:177–187. 2014. View Article : Google Scholar
|
|
29
|
Fei M, Hang Q, Hou S and Ruan C: Cell
adhesion to fibronectin down-regulates the expression of Spy1 and
contributes to drug resistance in multiple myeloma cells. Int J
Hematol. 98:446–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yagi K, Yamamoto K, Umeda S, Abe S, Suzuki
S, Onishi I, Kirimura S, Fukayama M, Arai A, Kitagawa M and Kurata
M: Expression of multidrug resistance 1 gene in B-cell lymphomas:
Association with follicular dendritic cells. Histopathology.
62:414–420. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kurtova AV, Tamayo AT, Ford RJ and Burger
JA: Mantle cell lymphoma cells express high levels of CXCR4, CXCR5,
and VLA-4 (CD49d): Importance for interactions with the stromal
microenvironment and specific targeting. Blood. 113:4604–4613.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guan C, Shi H, Wang H, Zhang J, Ni W, Chen
B, Hou S, Yang X, Shen A and Ni R: CtBP2 contributes to malignant
development of human esophageal squamous cell carcinoma by
regulation of p16INK4A. J Cell Biochem. 114:1343–1354. 2013.
View Article : Google Scholar
|
|
33
|
Tjin EP, Groen RW, Vogelzang I, Derksen
PW, Klok MD, Meijer HP, van Eeden S, Pals ST and Spaargaren M:
Functional analysis of HGF/MET signaling and aberrant HGF-activator
expression in diffuse large B-cell lymphoma. Blood. 107:760–768.
2006. View Article : Google Scholar
|
|
34
|
Fernandez-Vidal A, Ysebaert L, Didier C,
Betous R, De Toni F, Prade-Houdellier N, Demur C, Contour-Galcéra
MO, Prévost GP, Ducommun B, et al: Cell adhesion regulates CDC25A
expression and proliferation in acute myeloid leukemia. Cancer Res.
66:7128–7135. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Y, Huang Y, Xu X, Tang J, Huang X,
Zhu J, Liu J, Miao X, Wu Y, Yang F, et al: Expression of small
glutamine-rich TPR-containing protein A (SGTA) in Non-Hodgkin's
Lymphomas promotes tumor proliferation and reverses cell
adhesion-mediated drug resistance (CAM-DR). Leuk Res. 38:955–963.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He S, Huang Y, Wang Y, Tang J, Song Y, Yu
X, Ma J, Wang S, Yin H, Li Q, et al: Histamine-releasing
factor/translationally controlled tumor protein plays a role in
induced cell adhesion, apoptosis resistance and chemoresistance in
non-Hodgkin lymphomas. Leuk Lymphoma. 56:2153–2161. 2015.
View Article : Google Scholar
|
